Amman, June 8 (Petra)– The King Hussein Cancer Center (KHCC) has
been awarded accreditation by the Foundation for the Accreditation of
Cellular Therapy (FACT), one of the most prestigious international
accrediting bodies specializing in bone marrow transplantation and
cellular therapy. This achievement marks a significant milestone that
further strengthens the Center’s position as a regional and
international leader in providing advanced cancer care.

Dr. Phyllis Warkentin, Medical Director of FACT, stated: “We are
pleased to accredit the Bone Marrow Transplantation Program at King
Hussein Cancer Center following a series of on-site inspections
conducted by the FACT accreditation team to verify the program’s
compliance with international standards based on the latest
scientific advances in bone marrow transplantation and Good Tissue
Practice (GTP). The accreditation process also included a thorough
review of the Center’s documentation and records, which demonstrated
its full adherence to these standards.”

Dr. Asem Mansour, the CEO and Director General of King Hussein Cancer
Center, commented: “Obtaining FACT accreditation represents an
important milestone in the Center’s ongoing journey to strengthen its
role as a leading regional cancer center, providing a level of care
comparable to that offered by the world’s most advanced cancer
treatment institutions. This achievement reflects the unwavering
commitment of our medical, nursing, and technical teams to
maintaining the highest standards of quality and patient safety.”

Dr. Mansour also emphasized the importance of integrated
institutional collaboration, noting that this accomplishment was made
possible through the collective efforts of multidisciplinary teams
from across the Center. He further affirmed that KHCC will continue
investing in infrastructure development, enhancing workforce
capabilities, and expanding specialized services in alignment with
its mission and vision of providing patients with greater
opportunities for treatment and recovery.

For his part, Dr. Hassan Hashem, Director of the Bone Marrow
Transplantation and Cellular Therapy Program, explained that FACT
accreditation serves as international recognition of the quality and
excellence of the Center’s Bone Marrow Transplantation Program across
all stages of care, from cell collection and processing to
specialized clinical services.

He stated:”We are proud to have achieved these internationally
recognized standards, which ensure the highest levels of patient care
and safety. This accreditation reflects the quality of the program
and its compliance with rigorous international standards, thereby
strengthening confidence in its services and its ability to deliver
advanced therapies for patients with hematologic diseases and
cancer.”

Dr. Hashem noted that FACT is among the most specialized
accreditation bodies in this field, conducting comprehensive
evaluations of infrastructure, medical and nursing competencies,
quality systems, risk management practices, laboratories, and
cellular processing facilities. He added that FACT accreditation is
widely regarded as the gold standard for quality and safety in
cellular therapy and bone marrow transplantation.

Dr. Zaid Abdel Rahman, the FACT Accreditation Taskforce Leader,
highlighted that FACT accreditation reflects years of continuous
effort to establish, sustain, and advance a culture of quality,
safety, and continuous improvement. “We view this achievement not as
an endpoint, but as a foundation for sustained excellence and ongoing
advancement in the quality of care and services provided to our
patients,” he concluded.

//Petra//